Fedor N. Novikov

Lead Finder: An Approach To Improve Accuracy of Protein−Ligand Docking, Binding Energy Estimation, and Virtual Screening

Oleg V. Stroganov, Fedor N. Novikov, Viktor S. Stroylov et al. · Journal of Chemical Information and Modeling · 2008 · 220 citations

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Afsar Mian, Alireza Rafiei, Isabella Haberbosch et al. · Leukemia · 2014 · 64 citations

Hematological Malignancy, Tumor Biology, T315i Mutation +9

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin

Marina Sagnou, Fedor N. Novikov, Ekaterina S. Ivanova et al. · European Journal of Medicinal Chemistry · 2020 · 49 citations

Novel Curcumin Derivatives, Medicinal Chemistry, Multidrug Resistant Cells +13

Quantifying Possible Routes for SpnF-Catalyzed Formal Diels–Alder Cycloaddition

Michael G. Medvedev, Alexey A. Zeifman, Fedor N. Novikov et al. · Journal of the American Chemical Society · 2017 · 44 citations

Cross-coupling Reaction, Biosynthesis, Engineering +14

Lead Finder docking and virtual screening evaluation with Astex and DUD test sets

Fedor N. Novikov, Viktor S. Stroylov, Alexey A. Zeifman et al. · Journal of Computer-Aided Molecular Design · 2012 · 42 citations

Hit Identification, Lead Identification, Dud Test Sets +2